SuperMeds Corporation develops a new drug that controls severe acne. The drug is not approved by the government for sale in the United States because one of its ingredients is a banned chemical. This chemical is not banned in Mexico. Whether it is ethical for SuperMeds to sell the drug in Mexico depends on
A) theeffect of any "bad" publicity from the sale
B) the number of potential customers.
C) which legal standards are applied.
D) which ethical standards are applied.
D
You might also like to view...
Bid-rigging is a type of which of the following?
a. skimming b. bribery c. extortion d. illegal gratuity
Ratio analysis ________.
A) cannot be used to evaluate a company's financial condition B) is used most effectively to compare a company against other companies in the same industry and to denote trends within the company C) cannot be used to compare a company against other companies in the same industry because the necessary information is not available D) cannot be used to evaluate a company's performance
On December 31, 2009, Kallman Corporation had 160,000 shares of common stock issued and outstanding. On April 1, 2010, an additional 40,000 shares of common stock were issued for cash. During 2010, Kallman declared and paid dividends of $150,000 on its 20,000 shares of nonconvertible preferred stock. Net income for 2010 amounted to $400,000 . Kallman's earnings per share of common stock (rounded
to the nearest cent) for 2010 are a. $1.25. b. $1.32. c. $2.00. d. $2.11.
Markus, Inc produces a specialized machine part used in forklifts. For last year's operations, the following data were gathered: Units produced: 55,000 Direct labor: 29,000 hours @ $9.00 Actual variable overhead: $135,000 Markus employs a standard costing system. During the year, a variable overhead rate of $5.00 was used. The labor standard requires 0.50 hours per unit produced. The variable
overhead spending and efficiency variances are, respectively: A) $10,000 U and $7,500 U. B) $10,000 F and $7,500 U. C) $7,500 U and $10,000 F. D) $10,000 F and $7,500 F. E) none of these.